Itron (NASDAQ:ITRI) Now Covered by Analysts at Raymond James Financial

Raymond James Financial began coverage on shares of Itron (NASDAQ:ITRI) in a research report released on Tuesday, Marketbeat.com reports. The firm issued an underperform rating on the scientific and technical instruments company’s stock.

Several other research analysts have also recently weighed in on the company. Wall Street Zen cut Itron from a “buy” rating to a “hold” rating in a report on Wednesday, January 14th. Weiss Ratings cut Itron from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday, January 12th. Zacks Research upgraded Itron from a “strong sell” rating to a “hold” rating in a report on Thursday, February 26th. Robert W. Baird set a $128.00 target price on Itron and gave the stock an “outperform” rating in a report on Wednesday, February 18th. Finally, JPMorgan Chase & Co. lowered their target price on Itron from $133.00 to $113.00 and set an “overweight” rating on the stock in a report on Thursday, April 16th. Eight equities research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $133.10.

Itron Trading Down 3.6%

ITRI stock opened at $94.16 on Tuesday. The company has a current ratio of 1.80, a quick ratio of 1.56 and a debt-to-equity ratio of 0.45. Itron has a 12-month low of $83.51 and a 12-month high of $142.00. The stock has a market cap of $4.17 billion, a price-to-earnings ratio of 14.46, a PEG ratio of 0.84 and a beta of 1.50. The business’s 50-day moving average is $93.36 and its 200 day moving average is $101.00.

Itron (NASDAQ:ITRI) last posted its quarterly earnings data on Tuesday, February 17th. The scientific and technical instruments company reported $2.46 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.19 by $0.27. Itron had a return on equity of 20.04% and a net margin of 12.72%.The company had revenue of $571.66 million for the quarter, compared to analysts’ expectations of $561.31 million. During the same period in the previous year, the firm posted $1.35 EPS. Itron’s revenue was down 6.7% compared to the same quarter last year. Itron has set its Q1 2026 guidance at 1.200-1.300 EPS and its FY 2026 guidance at 5.750-6.250 EPS. On average, sell-side analysts anticipate that Itron will post 6.03 EPS for the current fiscal year.

Insider Buying and Selling at Itron

In other news, SVP Donald L. Reeves III sold 5,419 shares of Itron stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $99.54, for a total transaction of $539,407.26. Following the sale, the senior vice president owned 33,140 shares of the company’s stock, valued at approximately $3,298,755.60. The trade was a 14.05% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Justin K. Patrick sold 4,930 shares of Itron stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $99.54, for a total transaction of $490,732.20. Following the sale, the senior vice president directly owned 34,344 shares in the company, valued at approximately $3,418,601.76. The trade was a 12.55% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 51,180 shares of company stock worth $5,085,475. 1.77% of the stock is owned by company insiders.

Institutional Trading of Itron

Institutional investors have recently made changes to their positions in the company. Private Trust Co. NA raised its position in shares of Itron by 112.4% during the 4th quarter. Private Trust Co. NA now owns 274 shares of the scientific and technical instruments company’s stock valued at $25,000 after buying an additional 145 shares during the period. Employees Retirement System of Texas purchased a new stake in shares of Itron during the 3rd quarter valued at approximately $32,000. Optiver Holding B.V. purchased a new stake in shares of Itron during the 3rd quarter valued at approximately $36,000. Northwestern Mutual Wealth Management Co. raised its position in shares of Itron by 29.5% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 443 shares of the scientific and technical instruments company’s stock valued at $41,000 after buying an additional 101 shares during the period. Finally, Salomon & Ludwin LLC purchased a new stake in shares of Itron during the 3rd quarter valued at approximately $42,000. Hedge funds and other institutional investors own 96.19% of the company’s stock.

About Itron

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.